Amyvid
Payments companies reported to CMS as associated with Amyvid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Amyvid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Amyvid
These are the largest totals companies reported as associated with Amyvid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Phillip Kuo | Duarte, CA | Diagnostic Radiology | $9,664.01 |
| Santiago Restrepo | San Antonio, TX | Neurology (Psychiatry & Neurology) | $795.49 |
| Gretchen Campbell | Franklin, TN | Neurology (Psychiatry & Neurology) | $646.18 |
| April Stowers | Lee, FL | Family | $642.80 |
| Mary Monaco | Joliet, IL | Neurology (Psychiatry & Neurology) | $617.64 |
| Donald Mccarren | Bonita Springs, FL | Neurology (Psychiatry & Neurology) | $616.14 |
| Cindy Marshall | Dallas, TX | Geriatric Psychiatry | $592.12 |
| Wesley King | Birmingham, AL | Neurology (Psychiatry & Neurology) | $570.79 |
| Holly Horne | Fairhope, AL | Nurse Practitioner | $551.50 |
| Patricio Espinosa | Boca Raton, FL | Neuromusculoskeletal Medicine & Omm | $536.12 |
Prescribed Amyvid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.